<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article  PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "http://dtd.nlm.nih.gov/publishing/3.0/journalpublishing3.dtd"><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="3.0" xml:lang="en" article-type="research article"><front><journal-meta><journal-id journal-id-type="publisher-id">OALibJ</journal-id><journal-title-group><journal-title>Open Access Library Journal</journal-title></journal-title-group><issn pub-type="epub">2333-9705</issn><publisher><publisher-name>Scientific Research Publishing</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.4236/oalib.1103346</article-id><article-id pub-id-type="publisher-id">OALibJ-73660</article-id><article-categories><subj-group subj-group-type="heading"><subject>Articles</subject></subj-group><subj-group subj-group-type="Discipline-v2"><subject>Biomedical&amp;Life Sciences</subject><subject> Business&amp;Economics</subject><subject> Chemistry&amp;Materials Science</subject><subject> Computer Science&amp;Communications</subject><subject> Earth&amp;Environmental Sciences</subject><subject> Engineering</subject><subject> Medicine&amp;Healthcare</subject><subject> Physics&amp;Mathematics</subject><subject> Social Sciences&amp;Humanities</subject></subj-group></article-categories><title-group><article-title>
 
 
  A Rare Presentation of Central Nervous System Melioidosis
 
</article-title></title-group><contrib-group><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Shin-Shen</surname><given-names>Yong</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="corresp" rid="cor1"><sup>*</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Siti-Aisah</surname><given-names>Hassan</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Phing-Sue</surname><given-names>Wong</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Kar-Yaw</surname><given-names>Yoong</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib></contrib-group><aff id="aff1"><addr-line>Department of Internal Medicine, Hospital Sultan Ismail, Johor, Malaysia</addr-line></aff><aff id="aff2"><addr-line>Department of Radiology, Hospital Sultan Ismail, Johor, Malaysia</addr-line></aff><author-notes><corresp id="cor1">* E-mail:<email>emyong5@hotmail.com(SY)</email>;</corresp></author-notes><pub-date pub-type="epub"><day>04</day><month>01</month><year>2017</year></pub-date><volume>04</volume><issue>01</issue><fpage>1</fpage><lpage>8</lpage><history><date date-type="received"><day>December</day>	<month>30,</month>	<year>2016</year></date><date date-type="rev-recd"><day>Accepted:</day>	<month>January</month>	<year>17,</year>	</date><date date-type="accepted"><day>January</day>	<month>20,</month>	<year>2017</year></date></history><permissions><copyright-statement>&#169; Copyright  2014 by authors and Scientific Research Publishing Inc. </copyright-statement><copyright-year>2014</copyright-year><license><license-p>This work is licensed under the Creative Commons Attribution International License (CC BY). http://creativecommons.org/licenses/by/4.0/</license-p></license></permissions><abstract><p>
 
 
  We report a case of an 18-year-old army man who was diagnosed with cerebral melioidosis with disseminated abscesses. The patient presented with fever and focal neurological signs with positive cerebral imaging findings followed by a positive blood culture for 
  Burkholderia pseudomallei
  . Further imaging of other sites also revealed multiple abscesses. He responded well to an intensive course of antibiotic therapy of eight-week duration followed by 6 months of eradication therapy. The repeat cerebral imaging showed complete resolution of basal ganglia abscess at the end of intensive antibiotic therapy.
 
</p></abstract><kwd-group><kwd>Melioidosis</kwd><kwd> Basal Ganglia</kwd><kwd> Abscess</kwd><kwd> Antibiotic</kwd></kwd-group></article-meta></front><body><sec id="s1"><title>1. Introduction</title><p>Melioidosis is endemic in Southeast Asia and northern Australia and it is caused by Burkholderia pseudomallei [<xref ref-type="bibr" rid="scirp.73660-ref1">1</xref>] . It gains entry to the human host through skin abrasion, inhalation or ingestion. The clinical manifestations of melioidosis are variable and it commonly involves the lungs, visceral organs and occasionally musculoskeletal system with cerebral involvement being a rare presentation. The definite diagnosis is made by positive culture of the organism from blood or tissue biopsy. In endemic areas where the B. pseudomallei is detected in the blood culture or biopsy, the suspicion for systemic melioidosis should be raised.</p><p>Cerebral melioidosis are rarely reported and cases with disease presentations secondary to cranial abscesses are exceedingly rare [<xref ref-type="bibr" rid="scirp.73660-ref2">2</xref>] . The radiological features of cerebral melioidosis are variable and usually present as encephalitis or abscesses. Basal ganglia abscess is reported to be rare in central nervous system melioidosis. The duration of treatment depends on the site and extent of the infection. Prolonged intravenous (IV) therapy for four to eight weeks is needed for complicated infections such as cerebral melioidosis followed by eradication therapy.</p></sec><sec id="s2"><title>2. Case Presentation</title><p>An 18-year-old army man presented with intermittent fever for one week, associated with headache, chills and occasional dry cough. He was not known to have any previous medical illness. On physical examination, his Glasgow Coma Scale (GCS) score was full. However he appeared lethargic. He was febrile with a temperature of 38.7 degree Celsius. There was no significant abnormality detected on the cardiovascular, respiratory and abdominal examination. Neurological examination revealed upper motor neuron signs on the left lower limb with hypertonia, brisk knee and ankle reflexes, decreased in motor power to 4- (moving against slight resistance) with sustained ankle clonus and positive Babinski response. Neck stiffness and positive Brudzinski’s sign were present. Preliminary blood investigations showed leukocytosis, white cell count of 12.7 &#215; 10<sup>3</sup>/UL; and mild elevation of liver enzymes, aspartate aminotransferase of 250 u/L and alanine aminotransferase of 171 u/L (<xref ref-type="table" rid="table1">Table 1</xref>). The renal function test was within normal limits and blood and urine cultures sent for cultures. The chest radiograph was reported to be normal. In view of the history of fever with significant neurological deficit, an urgent plain computed tomography (CT) brain was done.</p><p>Immediate CT brain showed an ill-defined hypodense lesion at the right basal ganglia (<xref ref-type="fig" rid="fig1">Figure 1</xref>). He was then treated as for meningitis with IV ceftriaxone and IV acyclovir. Lumbar puncture (LP) was performed and the cerebrospinal fluid (CSF) sent for analysis. The CSF was reported acellular, clear in appearance with elevated protein level and low glucose level suggestive of bacterial meningitis. The CSF culture and gram staining showed no organisms. Magnetic resonance Imaging (MRI) of the brain with gadolinium contrast was done which showed a ring-enhancing lesion in the right basal ganglia with subdural effusion (<xref ref-type="fig" rid="fig2">Figure 2</xref>). Viral screening including Hepatitis B, C and Human-immunodefi- ciency Virus (HIV) were all non-reactive. He remained febrile on day 4 of admission and the blood culture grew Burkholderia pseudomallei. Bedside ultrasound of the abdomen revealed splenic micro-abscesses (<xref ref-type="fig" rid="fig3">Figure 3</xref>). A subsequent contrast enhanced CT of the thorax, abdomen and pelvis showed airspace opacities in the right lung, left lung consolidation and multiple splenic micro-abscesses (<xref ref-type="fig" rid="fig4">Figure 4</xref>).</p><p>The therapy was switched to the recommended antibiotic regime according to the Royal Darwin Melioidosis Guideline [<xref ref-type="bibr" rid="scirp.73660-ref3">3</xref>] that includes eight weeks of intensive phase of IV meropenem followed by six months of eradication therapy with trimethoprim-sulfamethoxazole and folic acid. At the end of the treatment, he</p><table-wrap id="table1" ><label><xref ref-type="table" rid="table1">Table 1</xref></label><caption><title> Laboratory investigations</title></caption><table><tbody><thead><tr><th align="center" valign="middle" >Variables</th><th align="center" valign="middle" >Normal range</th><th align="center" valign="middle" >On admission</th><th align="center" valign="middle" >After 2-weeks interval</th></tr></thead><tr><td align="center" valign="middle" >Hematocrit</td><td align="center" valign="middle" >40% - 54%</td><td align="center" valign="middle" >28.2</td><td align="center" valign="middle" >36.9</td></tr><tr><td align="center" valign="middle" >Hemoglobin</td><td align="center" valign="middle" >10 - 18 g/dL</td><td align="center" valign="middle" >9.3</td><td align="center" valign="middle" >12.4</td></tr><tr><td align="center" valign="middle" >White-cell count</td><td align="center" valign="middle" >4-11 &#215; 10<sup>3</sup>/UL</td><td align="center" valign="middle" >12.7</td><td align="center" valign="middle" >6.9</td></tr><tr><td align="center" valign="middle" >Differential count</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Neutrophils</td><td align="center" valign="middle" >(2.9 - 7.9) &#215; 10<sup>3</sup>/UL</td><td align="center" valign="middle" >8.7</td><td align="center" valign="middle" >3.3</td></tr><tr><td align="center" valign="middle" >Lymphocytes</td><td align="center" valign="middle" >(1.8 - 4.0) &#215; 10<sup>3</sup>/UL</td><td align="center" valign="middle" >1.3</td><td align="center" valign="middle" >2.6</td></tr><tr><td align="center" valign="middle" >Monocytes</td><td align="center" valign="middle" >(0.0 - 80.0) &#215; 10<sup>3</sup>/UL</td><td align="center" valign="middle" >0.7</td><td align="center" valign="middle" >0.4</td></tr><tr><td align="center" valign="middle" >Eosinophils</td><td align="center" valign="middle" >(0.4 - 2.1) &#215; 10<sup>3</sup>/UL</td><td align="center" valign="middle" >0.0</td><td align="center" valign="middle" >0.48</td></tr><tr><td align="center" valign="middle" >Basophils</td><td align="center" valign="middle" >(0.0 - 0.2) &#215; 10<sup>3</sup>/UL</td><td align="center" valign="middle" >0.0</td><td align="center" valign="middle" >0.0</td></tr><tr><td align="center" valign="middle" >Platelet count</td><td align="center" valign="middle" >(150 - 400) &#215; 10<sup>3</sup>/UL</td><td align="center" valign="middle" >220</td><td align="center" valign="middle" >396</td></tr><tr><td align="center" valign="middle" >C-reactive protein</td><td align="center" valign="middle" >0.0 - 5.0 mg/L</td><td align="center" valign="middle" >218.2</td><td align="center" valign="middle" >1.70</td></tr><tr><td align="center" valign="middle" >Potassium</td><td align="center" valign="middle" >3.5 - 5.0 mmol/L</td><td align="center" valign="middle" >3.4</td><td align="center" valign="middle" >3.6</td></tr><tr><td align="center" valign="middle" >Urea</td><td align="center" valign="middle" >1.7 - 8.3 mmol/L</td><td align="center" valign="middle" >5.0</td><td align="center" valign="middle" >3.5</td></tr><tr><td align="center" valign="middle" >Creatinine</td><td align="center" valign="middle" >62 - 106 &#181;mol/L</td><td align="center" valign="middle" >69</td><td align="center" valign="middle" >89</td></tr><tr><td align="center" valign="middle" >Glucose</td><td align="center" valign="middle" >3.1 - 6.4 mmol/L</td><td align="center" valign="middle" >4.4</td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Bilirubin</td><td align="center" valign="middle" >&lt;17 &#181;mol/L</td><td align="center" valign="middle" >37</td><td align="center" valign="middle" >7</td></tr><tr><td align="center" valign="middle" >Direct</td><td align="center" valign="middle" >0 - 5 &#181;mol/L</td><td align="center" valign="middle" >22</td><td align="center" valign="middle" >1</td></tr><tr><td align="center" valign="middle" >Protein</td><td align="center" valign="middle" >66 - 87 g/L</td><td align="center" valign="middle" >60</td><td align="center" valign="middle" >85</td></tr><tr><td align="center" valign="middle" >Albumin</td><td align="center" valign="middle" >34 - 48 g/L</td><td align="center" valign="middle" >17</td><td align="center" valign="middle" >40</td></tr><tr><td align="center" valign="middle" >Aspartate aminotransferase</td><td align="center" valign="middle" >0 - 38 u/L</td><td align="center" valign="middle" >250</td><td align="center" valign="middle" >21</td></tr><tr><td align="center" valign="middle" >Alanine aminotransferase</td><td align="center" valign="middle" >&lt;41 u/L</td><td align="center" valign="middle" >171</td><td align="center" valign="middle" >42</td></tr><tr><td align="center" valign="middle" >Alkaline phosphatase</td><td align="center" valign="middle" >0 - 129 u/L</td><td align="center" valign="middle" >153</td><td align="center" valign="middle" >100</td></tr><tr><td align="center" valign="middle" >Lactate Dehydrogenase</td><td align="center" valign="middle" >313 - 512 u/L</td><td align="center" valign="middle" >1548</td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Creatine Kinase</td><td align="center" valign="middle" >39 - 308 u/L</td><td align="center" valign="middle" >1748</td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >HbA1C</td><td align="center" valign="middle" ></td><td align="center" valign="middle" >5.8</td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >CSF Biochemistry</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Appearance</td><td align="center" valign="middle" ></td><td align="center" valign="middle" >Clear</td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >CSF Glucose</td><td align="center" valign="middle" >2.22 - 3.90 mmol/L</td><td align="center" valign="middle" >2.10</td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >CSF Protein</td><td align="center" valign="middle" >0.15 - 0.45 g/L</td><td align="center" valign="middle" >0.45</td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >CSF Albumin</td><td align="center" valign="middle" >g/L</td><td align="center" valign="middle" >0.19</td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >CSF Culture</td><td align="center" valign="middle" ></td><td align="center" valign="middle" >No growth</td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >CSF Cell count</td><td align="center" valign="middle" >Wbc/mL</td><td align="center" valign="middle" >Nil</td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >CSF Gram stain</td><td align="center" valign="middle" ></td><td align="center" valign="middle" >No organism seen</td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >CSF Acid Fast Bacilli culture</td><td align="center" valign="middle" ></td><td align="center" valign="middle" >Negative</td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >CSF Herpes Simplex Polymerase Chain Reaction</td><td align="center" valign="middle" ></td><td align="center" valign="middle" >Not detected</td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >CSF Toxoplasma antibody IgM</td><td align="center" valign="middle" ></td><td align="center" valign="middle" >Not detected</td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >CSF Toxoplasma antibody IgG</td><td align="center" valign="middle" ></td><td align="center" valign="middle" >Reactive</td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >CSF Mycobacterium Tuberculosis PCR</td><td align="center" valign="middle" ></td><td align="center" valign="middle" >Not detected</td><td align="center" valign="middle" ></td></tr></tbody></table></table-wrap><fig id="fig1"  position="float"><label><xref ref-type="fig" rid="fig1">Figure 1</xref></label><caption><title> Non-enhanced CT brain shows hypodense lesion in the right basal ganglion</title></caption><graphic mimetype="image"   position="float"  xlink:type="simple"  xlink:href="http://html.scirp.org/file/73660x2.png"/></fig><fig id="fig2"  position="float"><label><xref ref-type="fig" rid="fig2">Figure 2</xref></label><caption><title> Axial T2WI: High signal changes in the right basal ganglion with right subdural effusion</title></caption><graphic mimetype="image"   position="float"  xlink:type="simple"  xlink:href="http://html.scirp.org/file/73660x3.png"/></fig><fig id="fig3"  position="float"><label><xref ref-type="fig" rid="fig3">Figure 3</xref></label><caption><title> Splenic micro-abscesses on abdomen ultrasound</title></caption><graphic mimetype="image"   position="float"  xlink:type="simple"  xlink:href="http://html.scirp.org/file/73660x4.png"/></fig><fig id="fig4"  position="float"><label><xref ref-type="fig" rid="fig4">Figure 4</xref></label><caption><title> CT Thorax in lung setting showed air space opacities in the right lung with consolidation in the left lower lobe of the lung</title></caption><graphic mimetype="image"   position="float"  xlink:type="simple"  xlink:href="http://html.scirp.org/file/73660x5.png"/></fig><p>had gained full neurological recovery and the repeated CT scan after eight weeks of treatment showed complete resolution of the previous basal ganglion lesion and subdural effusion.</p></sec><sec id="s3"><title>3. Discussion</title><p>Melioidosis is an infectious disease caused by Burkholderia pseudomallei, which is endemic in the tropics [<xref ref-type="bibr" rid="scirp.73660-ref4">4</xref>] . It is a Gram-negative aerobic bacillus that gains entry to human host through skin abrasion, inhalation and ingestion. It has a predilection for multi-organ involvement and frequently involves the lungs, visceral organs, skin or soft tissue and rarely, meninges and the cerebrum. It has a variable clinical manifestation with non-specific radiological features and it requires a high index of clinical suspicion. The definitive diagnosis is made by presence of positive culture of the organism from blood or tissue [<xref ref-type="bibr" rid="scirp.73660-ref5">5</xref>] . Nevertheless, advanced imaging plays a pivotal role in establishing the extent of the disease, characterizing the lesion, making management decision, as well as following up on the disease progression.</p><p>The initial plain CT scan in this patient revealed a hypodense lesion in the right basal ganglion, leading to a possible diagnosis of encephalitis. MRI with gadolinium contrast was used to further delineate the lesion and revealed a solitary ring-enhancing lesion in the right basal ganglia with surrounding edema (<xref ref-type="fig" rid="fig5">Figure 5</xref>). Diffusion weighted imaging with apparent diffusion coefficient (ADP) mapping showed a central core of restricted diffusion, which is suggestive of an abscess (<xref ref-type="fig" rid="fig6">Figure 6</xref> and <xref ref-type="fig" rid="fig7">Figure 7</xref>) [<xref ref-type="bibr" rid="scirp.73660-ref6">6</xref>] . MR Imaging is sensitive in delineating the high signal changes of the cortex, basal ganglia, thalamus, cerebellum and midbrain while to rule out demyelination, abscess or tumour. Central nervous system melioidosis is rarely reported and mostly presents as meningoencephalitis with cerebral abscesses and brain stem involvement which can present as cranial nerve palsies, or flaccid paraparesis alone [<xref ref-type="bibr" rid="scirp.73660-ref7">7</xref>] . The biochemistry findings of the CSF from the LP and the presence of Burkholderia pseudomallei in serial blood cultures confirm the diagnosis of cerebral melioidosis with disseminated infection. The CSF analysis from patients with cerebral melioidosis often shows no organism on Gram staining, leukocytosis with mononuclear cell predominance, high protein level, and normal glucose level [<xref ref-type="bibr" rid="scirp.73660-ref8">8</xref>] [<xref ref-type="bibr" rid="scirp.73660-ref9">9</xref>] .</p><p>Basal ganglia are rare location for abscess formation. In adults, hematogenous brain abscesses usually occur at areas supplied by middle cerebral artery and very occasionally, in the deep tissues, such as basal ganglia and thalamus [<xref ref-type="bibr" rid="scirp.73660-ref10">10</xref>] . Streptococci and anaerobes are the most commonly encountered microorganisms in basal ganglia and thalamic abscesses [<xref ref-type="bibr" rid="scirp.73660-ref11">11</xref>] . Among the immunocompromised patients, basal ganglia is more commonly affected by toxoplasmosis and tuberculosis. Other differential diagnosis of a ring-enhancing lesion in the basal ganglia include glioblastoma, metastasis, and pyogenic abscess, subacute ischemic infarction, resolving hematoma, and demyelinating disease [<xref ref-type="bibr" rid="scirp.73660-ref12">12</xref>] .</p><p>Cerebral melioidosis is a rare manifestation of the infection and associated with melioidosis at other sites in up to 10% of cases [<xref ref-type="bibr" rid="scirp.73660-ref8">8</xref>] . Therefore, the findings</p><fig id="fig5"  position="float"><label><xref ref-type="fig" rid="fig5">Figure 5</xref></label><caption><title> Post Gadolinium axial T1WI ring-enhancing lesion in the right basal ganglion</title></caption><graphic mimetype="image"   position="float"  xlink:type="simple"  xlink:href="http://html.scirp.org/file/73660x6.png"/></fig><fig id="fig6"  position="float"><label><xref ref-type="fig" rid="fig6">Figure 6</xref></label><caption><title> Diffusion weighted image (4100/119, b value of 1000 s/mm<sup>2</sup>) shows high signal intensity, with low signal on ADC map represent restricted diffusion of the abscess core</title></caption><graphic mimetype="image"   position="float"  xlink:type="simple"  xlink:href="http://html.scirp.org/file/73660x7.png"/></fig><fig id="fig7"  position="float"><label><xref ref-type="fig" rid="fig7">Figure 7</xref></label><caption><title> Diffusion weighted image (4100/119, b value of 1000 s/mm<sup>2</sup>) shows high signal intensity, with low signal on ADC map represent restricted diffusion of the abscess core</title></caption><graphic mimetype="image"   position="float"  xlink:type="simple"  xlink:href="http://html.scirp.org/file/73660x8.png"/></fig><p>of cerebral melioidosis should prompt the clinicians and radiologists to look for other foci of infection. The ultrasound is sensitive in detection of visceral microabscesses but whole body CT scan provides a good information on the extent of the disease. The CT thorax is more sensitive and shows various manifestations of melioidosis infection in the lungs, from air space opacities and nodules, to cavitating lesions and consolidation, which may not be seen on the chest X ray.</p><p>In this case illustration, the patient presented with symptoms of meningoencephalitis initially. The subsequent discovery of Burkholderia pseudomallei in the blood culture prompted the clinicians to look for disseminated abscesses in</p><fig id="fig8"  position="float"><label><xref ref-type="fig" rid="fig8">Figure 8</xref></label><caption><title> Post treatment CECT brain at 3-month interval: Smaller ring enhancing lesion (2.3 mm &#215; 3.7 mm) with reducing edema</title></caption><graphic mimetype="image"   position="float"  xlink:type="simple"  xlink:href="http://html.scirp.org/file/73660x9.png"/></fig><p>other organs. Our patient responded well to eight-weeks duration of IV meropenem followed by recommended eradication therapy, which include six months of trimethoprim-sulfamethoxazole and folic acid. Repeated brain imaging at three-month interval showed a partial resolution of the basal ganglion abscess (<xref ref-type="fig" rid="fig8">Figure 8</xref>) while the repeated brain imaging at six-month intervals showed complete resolution of the ring enhancing lesion in the right basal ganglion and splenic micro- abscesses (image not shown) with full recovery of neurological deficits suggest of good treatment response. His basal ganglion abscess and subdural effusion were not drained as recommended by the neurosurgery team due to its location and difficulty in surgical approach. He is currently under our outpatient follow up for the surveillance of reactivation of the disease.</p></sec><sec id="s4"><title>4. Learning Points</title><p>The common clinical manifestations of melioidosis infection are pneumonia and localized skin involvement. Culture remains the mainstay of the diagnosis with Gram stain revealing gram-negative bacilli of B. pseudomallei. Melioidosis presenting as cerebral abscesses carries a high mortality rate. When encephalomyelitis or brain abscesses are suspected, MRI brain is helpful to delineate the CNS involvement [<xref ref-type="bibr" rid="scirp.73660-ref9">9</xref>] . Prolonged course of antibiotic treatment is indicated in complicated infection and eradication therapy is needed as B. pseudomallei have the potential to reactivate, with a latent period that can last up to decades.</p></sec><sec id="s5"><title>5. Patient’s Consent</title><p>Explicit consent from the patient illustrated in this case had been obtained for the medical details and radiographic images to be used for publication purposes.</p></sec><sec id="s6"><title>Acknowledgements</title><p>We thank Dr Rafidah Binti Atan and Dr Naganathan Pillai for their comments that have greatly improved the manuscripts.</p></sec><sec id="s7"><title>Cite this paper</title><p>Yong, S.-S., Hassan, S.-A., Wong, P.-S. and Yoong, K.-Y. (2017) A Rare Presentation of Central Nervous System Melioidosis. Open Access Library Journal, 4: e3346. http://dx.doi.org/10.4236/oalib.1103346</p></sec></body><back><ref-list><title>References</title><ref id="scirp.73660-ref1"><label>1</label><mixed-citation publication-type="other" xlink:type="simple">Cheng, A.C. and Currie, B.J. (2005) Melioidosis: Epidemiology, Pathophysiology, and Management. Clinical Microbiology Reviews, 18, 383-416. https://doi.org/10.1128/CMR.18.2.383-416.2005</mixed-citation></ref><ref id="scirp.73660-ref2"><label>2</label><mixed-citation publication-type="other" xlink:type="simple">Currie, B.J., Ward, L. and Cheng, A.C. (2010) The Epidemiology and Clinical Spectrum of Melioidosis: 540 Cases from the 20 Year Darwin Prospective Study. PLOS Neglected Tropical Diseases, 4, e900. https://doi.org/10.1371/journal.pntd.0000900</mixed-citation></ref><ref id="scirp.73660-ref3"><label>3</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Currie</surname><given-names> B. </given-names></name>,<etal>et al</etal>. (<year>2014</year>)<article-title>Melioidosis: The 2014 Revised RDH Guideline</article-title><source> The Northern Territory Disease Control Bulletin</source><volume> 21</volume>,<fpage> 4</fpage>-<lpage>8</lpage>.<pub-id pub-id-type="doi"></pub-id></mixed-citation></ref><ref id="scirp.73660-ref4"><label>4</label><mixed-citation publication-type="other" xlink:type="simple">Wiersinga, W.J., Currie, B.J. and Peacock, S.J. (20120 Melioidosis. The New England Journal of Medicine, 367, 1035-1044. https://doi.org/10.1056/NEJMra1204699</mixed-citation></ref><ref id="scirp.73660-ref5"><label>5</label><mixed-citation publication-type="other" xlink:type="simple">Muttarak, M., et al. (2009) Spectrum of Imaging Findings in Melioidosis. The British Journal of Radiology, 82, 514-521. https://doi.org/10.1259/bjr/15785231</mixed-citation></ref><ref id="scirp.73660-ref6"><label>6</label><mixed-citation publication-type="other" xlink:type="simple">Tung, G.A., et al. (2001) Diffusion-Weighted MR Imaging of Rim-Enhancing Brain Masses: Is Markedly Decreased Water Diffusion Specific for Brain Abscess? American Journal of Roentgenology, 177, 709-712. https://doi.org/10.2214/ajr.177.3.1770709</mixed-citation></ref><ref id="scirp.73660-ref7"><label>7</label><mixed-citation publication-type="other" xlink:type="simple">Woods 2nd, M.L., et al. (1992) Neurological Melioidosis: Seven Cases from the Northern Territory of Australia. Clinical Infectious Diseases, 15, 163-169. https://doi.org/10.1093/clinids/15.1.163</mixed-citation></ref><ref id="scirp.73660-ref8"><label>8</label><mixed-citation publication-type="other" xlink:type="simple">Currie, B.J., et al. (2000) Neurological Melioidosis. Acta Tropica, 74, 145-151. https://doi.org/10.1016/S0001-706X(99)00064-9</mixed-citation></ref><ref id="scirp.73660-ref9"><label>9</label><mixed-citation publication-type="other" xlink:type="simple">Padiglione, A., et al. (1998) Brain Abscesses Caused by Burkholderia pseudomallei. Journal of Infection, 36, 335-337. https://doi.org/10.1016/S0163-4453(98)94639-4</mixed-citation></ref><ref id="scirp.73660-ref10"><label>10</label><mixed-citation publication-type="other" xlink:type="simple">Kilic, O., et al. (2012) Primary Intracranial Abscess Localized in the Basal Ganglia: A Case Report. Journal of Tropical Pediatrics, 58, 71-73. https://doi.org/10.1093/tropej/fmr019</mixed-citation></ref><ref id="scirp.73660-ref11"><label>11</label><mixed-citation publication-type="other" xlink:type="simple">Lutz, T.W., et al. (1994) Diagnosis and Management of Abscesses in the Basal Ganglia and Thalamus: A Survey. Acta Neurochirurgica (Wien), 127, 91-98. https://doi.org/10.1007/BF01808554</mixed-citation></ref><ref id="scirp.73660-ref12"><label>12</label><mixed-citation publication-type="other" xlink:type="simple">Hartmann, M., et al. (2001) Restricted Diffusion within Ring Enhancement Is Not Pathognomonic for Brain Abscess. American Journal of Neuroradiology, 22, 1738- 1742.</mixed-citation></ref></ref-list></back></article>